About this Research Topic
Given the success of Research Topic Novel Treatment Strategies for Thyroid Autoimmunity and Thyroid Cancer and the rapidly evolving subject area, we are pleased to announce this new collection focusing on Thyroid Cancer.
Thyroid cancer, the most prevalent endocrine malignancy, poses a significant global health burden. Conventional treatments such as surgery, radioiodine therapy, and thyroid hormone suppression have shown efficacy, but refractory cases and recurrence remain notable challenges.
In recent years promising strides in novel treatments for thyroid cancer have been made. Advancements in targeted therapies, immunotherapies, and precision medicine have emerged as potential breakthroughs in managing aggressive and refractory cases.
This Research Topic welcomes contributions of any type (clinical trial, correction, editorial, general commentary, hypothesis & theory, methods, mini review, opinion, original research, perspective, policy and practice reviews, review, study protocol, systematic review, technology and code) on topics around recent studies on new treatment strategies for patients with thyroid cancer such as:
• Targeted Therapies: Precision drugs targeting genetic mutations (e.g., BRAF, RET) show promising outcomes.
• Precision Medicine: Utilizing molecular profiling for tailored, patient-specific treatment approaches.
• Combination Therapies: Synergistic effects of combining different treatment modalities for improved outcomes.
• Gene Therapy: Innovative approaches targeting genetic aberrations for therapeutic interventions.
• Tumor Microenvironment Targeting: Strategies focusing on disrupting tumor support networks.
Thyroid cancer, the most prevalent endocrine malignancy, poses a significant global health burden. Conventional treatments such as surgery, radioiodine therapy, and thyroid hormone suppression have shown efficacy, but refractory cases and recurrence remain notable challenges.
In recent years promising strides in novel treatments for thyroid cancer have been made. Advancements in targeted therapies, immunotherapies, and precision medicine have emerged as potential breakthroughs in managing aggressive and refractory cases.
This Research Topic welcomes contributions of any type (clinical trial, correction, editorial, general commentary, hypothesis & theory, methods, mini review, opinion, original research, perspective, policy and practice reviews, review, study protocol, systematic review, technology and code) on topics around recent studies on new treatment strategies for patients with thyroid cancer such as:
• Targeted Therapies: Precision drugs targeting genetic mutations (e.g., BRAF, RET) show promising outcomes.
• Precision Medicine: Utilizing molecular profiling for tailored, patient-specific treatment approaches.
• Combination Therapies: Synergistic effects of combining different treatment modalities for improved outcomes.
• Gene Therapy: Innovative approaches targeting genetic aberrations for therapeutic interventions.
• Tumor Microenvironment Targeting: Strategies focusing on disrupting tumor support networks.
Keywords: Thyroid, Thyroid Disease, Hypothyroidism, Hyperthyroidism, Thyroid Cancer
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
